| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 09/16/2002 | CA2376738A1 Purine derivatives for the treatment of ischemia |
| 09/12/2002 | WO2002070534A1 C2, 8-disubstituted adenosine derivatives and their different uses |
| 09/12/2002 | WO2002070533A2 Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides |
| 09/12/2002 | WO2002070532A2 C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses |
| 09/12/2002 | WO2002069982A1 Medicaments |
| 09/12/2002 | WO2002069903A2 Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases |
| 09/12/2002 | WO2000053616A3 Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage |
| 09/12/2002 | US20020128467 Generating 5'-deoxy-5-fluorouridine; react 2',3'-O-isopropylidene-5- fluorouridine with a sulfonic derivative, hydrolyze, expose to iodine derivative, recover 5'-deoxy- 5'-iodo-5-fluorouridine, |
| 09/12/2002 | US20020128301 Non-nucleoside reverse transcriptase inhibitors |
| 09/12/2002 | US20020128224 Administering a nucleoside 5'-pyrophosphate pyranoside or analogue, of given formula |
| 09/12/2002 | US20020128223 Methods for modulating the axonal outgrowth of central nervous system neurons |
| 09/12/2002 | US20020128195 Hydrophilic polymer covalently and reversibly linked to amine-containing ligand through dithiobenzyl linkage; improves blood circulation time |
| 09/12/2002 | US20020127598 Modulator for use in the diagnosis, treatment and prevention of bacterial and viral infection |
| 09/12/2002 | DE10108851A1 Verwendung von 5'-substituierten Nukleosiden und/oder deren Prodrugs zur resistenzfreien Therapie von Infektionskrankheiten Use of 5'-substituted nucleosides and / or their prodrugs for the resistance-free therapy of infectious diseases |
| 09/12/2002 | CA2439836A1 Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides |
| 09/11/2002 | EP1237898A2 N?6 heterocyclic 8-modified adenosine derivatives |
| 09/10/2002 | US6448407 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis |
| 09/10/2002 | US6448392 Lipid, especially phospholipid, derivatives of modified antiviral nucleoside analogues can be integrated into structure of liposomes, forming stable liposomal complex, deliver greater amounts of drugs to cells with less toxicity |
| 09/10/2002 | US6448236 Functional agonists of the human adenosine a2a receptor and may be used as, for example, anti-inflammatory agents in the treatment of repiratory diseases |
| 09/10/2002 | US6448065 Integrated sequencing device |
| 09/10/2002 | US6448008 Fluorescent cyanine labels containing a sulfamido linker arm |
| 09/10/2002 | US6447998 Method of detecting the presence, absence or amount of a particular dna duplex in a sample suspected of containing dna comprising contacting the sample with an oligomer of under conditions wherein a triple helix is formed between the |
| 09/06/2002 | WO2002068537A2 Fluorescent dye |
| 09/06/2002 | WO2002068443A1 Process for the preparation of (e)-5-(2-bromovinyl)-2'-deoxyuridine |
| 09/06/2002 | WO2002068442A1 Salts of avermectins substituted in the 4'-position and having pesticidal properties |
| 09/06/2002 | WO2002068441A2 Avermectins substituted in the 4'-position having pesticidal properties |
| 09/06/2002 | WO2002068437A1 Protected deoxyadenosines and deoxyguanosines |
| 09/06/2002 | WO2002067951A2 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |
| 09/06/2002 | WO2002020842A8 System, method and apparatus for transgenic and targeted mutagenesis screening |
| 09/06/2002 | WO2002020537A3 Linker phosphoramidites for oligonucleotide synthesis |
| 09/06/2002 | WO2001049687A9 Cyclohexene nucleic acids |
| 09/06/2002 | CA2439407A1 Protected deoxyadenosines and deoxyguanosines |
| 09/05/2002 | US20020123032 Detection of disease related genes |
| 09/05/2002 | DE10109657A1 Verfahren zur Herstellung von (E)-5-(2-Bromvinyl)-2`-desoxyuridin A process for the preparation of (E) -5- (2-bromovinyl) deoxyuridine--2` |
| 09/04/2002 | EP1236736A1 2-aminopurine derivatives |
| 09/04/2002 | EP1235929A2 Replica amplification of nucleic acid arrays |
| 09/04/2002 | EP1056759B1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives |
| 09/04/2002 | EP0724587B1 Ring-expanded nucleosides and nucleotides |
| 09/03/2002 | US6444798 Genetic engineering |
| 09/03/2002 | US6444682 Base analogues |
| 09/03/2002 | US6444656 Antiviral phosphonate nucleotides |
| 09/03/2002 | US6444652 ADMINISTERING BETA-L-2'-DEOXYNUCLEOSIDE DERIVATIVES FOR TREATMENT OR PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION IN HOST; telbuvidine for example |
| 09/03/2002 | US6444423 First single stranded nucleic acid containing at least one covalently attached electron donor moiety and a second single stranded nucleic acid containing at least one covalently attached electron acceptor moiety, wherein at least one of |
| 08/29/2002 | WO2002066020A2 Modulation of gsk-3beta activity and its different uses |
| 08/29/2002 | WO2002008241A3 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 08/29/2002 | WO2001010882A9 Depot forms of modified nucleoside 5'-hydrogenphosphates as inhibitors of reproduction of human immunodeficiency virus and human hepatitis b virus |
| 08/29/2002 | US20020120130 Stereospecific preparation; use of 2',3' dideoxy-beta-L-fluorocytidine, as antiviral agent against HIV |
| 08/29/2002 | US20020120129 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives |
| 08/29/2002 | US20020120127 Replica amplification of nucleic acid arrays |
| 08/29/2002 | US20020120126 Making and using immobilized arrays of nucleic acids; improve the efficiency of multiplex polymerase chain reaction (PCR) using arrays of immobilized nucleic acids |
| 08/29/2002 | US20020119534 Stabilized aqueous nucleoside triphosphate solutions |
| 08/29/2002 | US20020119443 Screening preferential prodrugs for use in viral therapy; obtain target tissue, incubate with prodrug, monitor and evaluate prodrug activity in tissues |
| 08/29/2002 | US20020119150 Administering an effective amount of a CD40:CD154 binding interrupter to primate graft recipient for therapy of rejection of tissue graft |
| 08/29/2002 | US20020119094 Nucleosides for imaging and treatment applications |
| 08/28/2002 | EP1233973A1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 08/28/2002 | EP1233770A2 Phosphonate compounds |
| 08/28/2002 | EP1159282A4 Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds |
| 08/28/2002 | EP1043329B1 Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same, and method for producing said compound |
| 08/28/2002 | EP0806956B1 Use of 5'substituted nucleosides to provide resistance in cytostatic treatment |
| 08/28/2002 | CN1366530A Process for preparation of trifluorothymidine derivatives |
| 08/28/2002 | CN1365976A Process for extracting medicinal component from pueraria root |
| 08/27/2002 | US6441161 Urea nucleosides as therapeutic and diagnostic agents |
| 08/27/2002 | US6440948 Thiophene A2A receptor agonists |
| 08/27/2002 | US6440943 Mimic and/or modulate the activity of wild-type nucleic acids; the 5' and the 3'-terminal internucleoside linkages are chirally sp and internal internucleoside linkages are chirally rp; resistant to nuclease degradation; psoriasis |
| 08/27/2002 | US6440705 Detection of variance in nucleotide sequence without the need for full sequence determination; genotyping and labeling while cleaving dna strands; electrophoresis |
| 08/27/2002 | US6440667 Analysis of target molecules using an encoding system |
| 08/27/2002 | US6440455 Methods for modulating the axonal outgrowth of central nervous system neurons |
| 08/27/2002 | CA2085354C Ether lipid-nucleoside covalent conjugates |
| 08/22/2002 | WO2002064609A1 Crystal of pyrimidine nucleoside derivative |
| 08/22/2002 | WO2000006771A9 Nucleic acid labeling compounds |
| 08/22/2002 | US20020115635 Modulation of GSK-3beta activity and its different uses |
| 08/22/2002 | US20020115092 Label for use in nucleotide sequence analysis |
| 08/22/2002 | US20020115076 System and apparatus for nucleic acid sequencing of single molecules by polymerase synthesis |
| 08/22/2002 | US20020115067 Asymmetric benzoxanthene dye labelling reagents |
| 08/21/2002 | EP1232172A1 Novel ribose compounds |
| 08/21/2002 | EP1232166A2 Synthesis of 2'-deoxy-l-nucleosides |
| 08/21/2002 | EP1231844A1 Polycyclic quinone and ionophore composition for the synergistic reduction of methane formation in ruminant animals |
| 08/21/2002 | EP1151350A4 Protecting groups with increased photosensitivities |
| 08/21/2002 | CN1365395A Tenascin-C nucleic acid liqands |
| 08/21/2002 | CN1089239C Pyrimidine nucleotide precursors of treatment of animal inflammations and tissue damages |
| 08/20/2002 | US6438244 Hearing aid construction with electronic components encapsulated in soft polymeric body |
| 08/20/2002 | US6437118 Reacting 4-amino-1h-pyrmidin-2-one with vinyl borane in presence of palladium complex and base |
| 08/20/2002 | US6436437 Covalent polar lipid conjugates with neurologically active compounds for targeting |
| 08/20/2002 | CA2024825C 13-halo-23-imino derivatives of ll-f28249 compounds and their use as endo- and ectoparasiticidal insecticidal, acaricidal and nematocidal agents |
| 08/15/2002 | WO2002062816A1 Non-natural nucleotides and dinucleotides |
| 08/15/2002 | WO2002062815A1 Hybrid protecting groups |
| 08/15/2002 | WO2002062814A1 Inhibitors of glycosyltransferase enzymes |
| 08/15/2002 | WO2002062811A2 Improved methods for synthesis of oligonucleotides |
| 08/15/2002 | WO2002062747A1 Photolabile protective groups for the synthesis of biopolymers |
| 08/15/2002 | WO2002062123A2 Novel compounds and methods for inhibiting/treating hiv infections and aids related symptoms |
| 08/15/2002 | WO2002016381B1 Composition and method for inhibiting platelet aggregation |
| 08/15/2002 | WO2002008446A3 Synthesis and antiviral evaluation of nucleic acid based (nab) libraries |
| 08/15/2002 | WO2001079246A3 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
| 08/15/2002 | WO2001028545A9 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 08/15/2002 | US20020111496 Inhibitors of glycosyltransferase enzymes |
| 08/15/2002 | US20020111375 Antitumor agents |
| 08/15/2002 | US20020111291 Diabetic therapy |
| 08/14/2002 | EP1231282A2 Methods and compositions for identification of polymers |
| 08/14/2002 | EP1231211A1 Thiazolidinedione derivatives as antidiabetic agents |
| 08/14/2002 | EP1230925A1 Anti-hiv compositions |